ID

31639

Beschrijving

Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers; ODM derived from: https://clinicaltrials.gov/show/NCT00984919

Link

https://clinicaltrials.gov/show/NCT00984919

Trefwoorden

Versies (1)
  1. 15-09-18 15-09-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

15 september 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Prostate Cancer NCT00984919

Engels

Eligibility Prostate Cancer NCT00984919

1 Formulieren  
Criteria
Beschrijving

Criteria

meets one of the following criteria:
Beschrijving

Criteria Quantity Fulfill

Datatype

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C1550543
histopathologically confirmed prostate cancer meeting 1 of the following criteria:
Beschrijving

Prostate carcinoma | Criteria Quantity Fulfill

Datatype

boolean

Alias
UMLS CUI [1]
C0600139
UMLS CUI [2,1]
C0243161
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C1550543
newly diagnosed untreated disease
Beschrijving

Disease untreated

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332155
received prior local therapy (prostatectomy, definitive radiotherapy, brachytherapy, or cryotherapy) with no evidence of disease activity (defined as serum psa < 0.4 ng/ml post therapy) and by imaging studies
Beschrijving

Local Therapy | Prostatectomy | Therapeutic radiology procedure Definitive | Brachytherapy | Cold Therapy | Disease remission Imaging studies | Prostate specific antigen measurement Post Therapeutic procedure

Datatype

boolean

Alias
UMLS CUI [1]
C1517925
UMLS CUI [2]
C0033573
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0443196
UMLS CUI [4]
C0006098
UMLS CUI [5]
C0010412
UMLS CUI [6,1]
C0544452
UMLS CUI [6,2]
C1881134
UMLS CUI [7,1]
C0201544
UMLS CUI [7,2]
C0687676
UMLS CUI [7,3]
C0087111
experienced biochemical failure (defined as rise in serum psa ≥ 0.4 ng/ml post therapy)
Beschrijving

Therapeutic procedure Biochemical failed | Raised prostate specific antigen Post Therapeutic procedure

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0205474
UMLS CUI [1,3]
C0231175
UMLS CUI [2,1]
C0178415
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C0087111
healthy volunteer (clinic patient with no history of clinically significant malignancies within the past 6 months)
Beschrijving

Healthy Volunteer | Malignant Neoplasms Absent

Datatype

boolean

Alias
UMLS CUI [1]
C1708335
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0332197
patient characteristics:
Beschrijving

Client Characteristics

Datatype

boolean

Alias
UMLS CUI [1]
C0815172
no clinical evidence of liver cirrhosis or chronic liver disease (i.e., evidence of ascites or severe coagulopathy)
Beschrijving

Liver Cirrhosis Absent | Chronic liver disease Absent | Ascites | Blood Coagulation Disorder Severe

Datatype

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0341439
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0003962
UMLS CUI [4,1]
C0005779
UMLS CUI [4,2]
C0205082
no active prostatitis
Beschrijving

Prostatitis Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0033581
UMLS CUI [1,2]
C0332197
prior concurrent therapy:
Beschrijving

Therapeutic procedure

Datatype

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Beschrijving

ID.11

Datatype

boolean

more than 30 days since prior and no concurrent regular antiplatelet agents (including aspirin, anagrelide, cilastazole, clopidogrel, dipyridamole, pentoxiphylline, sulfinpyrazone, or ticlopidine)
Beschrijving

Antiplatelet Agents Absent | Aspirin Absent | Anagrelide Absent | Cilostazol Absent | Clopidogrel Absent | Dipyridamole Absent | Pentoxifylline Absent | Sulfinpyrazone Absent | Ticlopidine Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0085826
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0004057
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0051809
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0055729
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0070166
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0012582
UMLS CUI [6,2]
C0332197
UMLS CUI [7,1]
C0030899
UMLS CUI [7,2]
C0332197
UMLS CUI [8,1]
C0038742
UMLS CUI [8,2]
C0332197
UMLS CUI [9,1]
C0040207
UMLS CUI [9,2]
C0332197
more than 7 days since prior and no concurrent nsaids (including ibuprofen, celecoxib, diclofenac, diflunisal, etodolac, fenoprofen, flurbiprofen, indomethacin, ketoprofen, meclofenamate, mefenamic acid, nabumetone, naproxen, oxaprozin, piroxicam, sulindac, or tolmetin)
Beschrijving

NSAIDs Absent | Ibuprofen Absent | Celecoxib Absent | Diclofenac Absent | Diflunisal Absent | Etodolac Absent | Fenoprofen Absent | Flurbiprofen Absent | Indomethacin Absent | Ketoprofen Absent | Meclofenamate Absent | Mefenamic Acid Absent | Nabumetone Absent | Naproxen Absent | Oxaprozin Absent | Piroxicam Absent | Sulindac Absent | Tolmetin Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0003211
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0020740
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C0538927
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0012091
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0012228
UMLS CUI [5,2]
C0332197
UMLS CUI [6,1]
C0059865
UMLS CUI [6,2]
C0332197
UMLS CUI [7,1]
C0015837
UMLS CUI [7,2]
C0332197
UMLS CUI [8,1]
C0016377
UMLS CUI [8,2]
C0332197
UMLS CUI [9,1]
C0021246
UMLS CUI [9,2]
C0332197
UMLS CUI [10,1]
C0022635
UMLS CUI [10,2]
C0332197
UMLS CUI [11,1]
C1289957
UMLS CUI [11,2]
C0332197
UMLS CUI [12,1]
C0025152
UMLS CUI [12,2]
C0332197
UMLS CUI [13,1]
C0068334
UMLS CUI [13,2]
C0332197
UMLS CUI [14,1]
C0027396
UMLS CUI [14,2]
C0332197
UMLS CUI [15,1]
C0069739
UMLS CUI [15,2]
C0332197
UMLS CUI [16,1]
C0031990
UMLS CUI [16,2]
C0332197
UMLS CUI [17,1]
C0038792
UMLS CUI [17,2]
C0332197
UMLS CUI [18,1]
C0040377
UMLS CUI [18,2]
C0332197
Terug naar het begin van de pagina

Similar models

Eligibility Prostate Cancer NCT00984919

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Criteria Quantity Fulfill
Item
meets one of the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Prostate carcinoma | Criteria Quantity Fulfill
Item
histopathologically confirmed prostate cancer meeting 1 of the following criteria:
boolean
C0600139 (UMLS CUI [1])
C0243161 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1550543 (UMLS CUI [2,3])
Disease untreated
Item
newly diagnosed untreated disease
boolean
C0012634 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Local Therapy | Prostatectomy | Therapeutic radiology procedure Definitive | Brachytherapy | Cold Therapy | Disease remission Imaging studies | Prostate specific antigen measurement Post Therapeutic procedure
Item
received prior local therapy (prostatectomy, definitive radiotherapy, brachytherapy, or cryotherapy) with no evidence of disease activity (defined as serum psa < 0.4 ng/ml post therapy) and by imaging studies
boolean
C1517925 (UMLS CUI [1])
C0033573 (UMLS CUI [2])
C1522449 (UMLS CUI [3,1])
C0443196 (UMLS CUI [3,2])
C0006098 (UMLS CUI [4])
C0010412 (UMLS CUI [5])
C0544452 (UMLS CUI [6,1])
C1881134 (UMLS CUI [6,2])
C0201544 (UMLS CUI [7,1])
C0687676 (UMLS CUI [7,2])
C0087111 (UMLS CUI [7,3])
Therapeutic procedure Biochemical failed | Raised prostate specific antigen Post Therapeutic procedure
Item
experienced biochemical failure (defined as rise in serum psa ≥ 0.4 ng/ml post therapy)
boolean
C0087111 (UMLS CUI [1,1])
C0205474 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0178415 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Healthy Volunteer | Malignant Neoplasms Absent
Item
healthy volunteer (clinic patient with no history of clinically significant malignancies within the past 6 months)
boolean
C1708335 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Liver Cirrhosis Absent | Chronic liver disease Absent | Ascites | Blood Coagulation Disorder Severe
Item
no clinical evidence of liver cirrhosis or chronic liver disease (i.e., evidence of ascites or severe coagulopathy)
boolean
C0023890 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0341439 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0003962 (UMLS CUI [3])
C0005779 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
Prostatitis Absent
Item
no active prostatitis
boolean
C0033581 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.11
Item
see disease characteristics
boolean
Antiplatelet Agents Absent | Aspirin Absent | Anagrelide Absent | Cilostazol Absent | Clopidogrel Absent | Dipyridamole Absent | Pentoxifylline Absent | Sulfinpyrazone Absent | Ticlopidine Absent
Item
more than 30 days since prior and no concurrent regular antiplatelet agents (including aspirin, anagrelide, cilastazole, clopidogrel, dipyridamole, pentoxiphylline, sulfinpyrazone, or ticlopidine)
boolean
C0085826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0051809 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0055729 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0070166 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0012582 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0030899 (UMLS CUI [7,1])
C0332197 (UMLS CUI [7,2])
C0038742 (UMLS CUI [8,1])
C0332197 (UMLS CUI [8,2])
C0040207 (UMLS CUI [9,1])
C0332197 (UMLS CUI [9,2])
NSAIDs Absent | Ibuprofen Absent | Celecoxib Absent | Diclofenac Absent | Diflunisal Absent | Etodolac Absent | Fenoprofen Absent | Flurbiprofen Absent | Indomethacin Absent | Ketoprofen Absent | Meclofenamate Absent | Mefenamic Acid Absent | Nabumetone Absent | Naproxen Absent | Oxaprozin Absent | Piroxicam Absent | Sulindac Absent | Tolmetin Absent
Item
more than 7 days since prior and no concurrent nsaids (including ibuprofen, celecoxib, diclofenac, diflunisal, etodolac, fenoprofen, flurbiprofen, indomethacin, ketoprofen, meclofenamate, mefenamic acid, nabumetone, naproxen, oxaprozin, piroxicam, sulindac, or tolmetin)
boolean
C0003211 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0020740 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0538927 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0012091 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0012228 (UMLS CUI [5,1])
C0332197 (UMLS CUI [5,2])
C0059865 (UMLS CUI [6,1])
C0332197 (UMLS CUI [6,2])
C0015837 (UMLS CUI [7,1])
C0332197 (UMLS CUI [7,2])
C0016377 (UMLS CUI [8,1])
C0332197 (UMLS CUI [8,2])
C0021246 (UMLS CUI [9,1])
C0332197 (UMLS CUI [9,2])
C0022635 (UMLS CUI [10,1])
C0332197 (UMLS CUI [10,2])
C1289957 (UMLS CUI [11,1])
C0332197 (UMLS CUI [11,2])
C0025152 (UMLS CUI [12,1])
C0332197 (UMLS CUI [12,2])
C0068334 (UMLS CUI [13,1])
C0332197 (UMLS CUI [13,2])
C0027396 (UMLS CUI [14,1])
C0332197 (UMLS CUI [14,2])
C0069739 (UMLS CUI [15,1])
C0332197 (UMLS CUI [15,2])
C0031990 (UMLS CUI [16,1])
C0332197 (UMLS CUI [16,2])
C0038792 (UMLS CUI [17,1])
C0332197 (UMLS CUI [17,2])
C0040377 (UMLS CUI [18,1])
C0332197 (UMLS CUI [18,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial